These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36079129)

  • 1. Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema.
    Toto L; D'Aloisio R; Quarta A; Libertini D; D'Onofrio G; De Nicola C; Romano A; Mastropasqua R
    J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
    Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
    Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anti-VEGF monotherapy versus anti-VEGF therapy with subthreshold micropulse laser (SML) in the management of diabetic macular oedema (DMO): a systematic review and meta-analysis.
    Wijeweera C; Ni J; Petocz P; Preda V; Jabbour J
    Graefes Arch Clin Exp Ophthalmol; 2024 Sep; 262(9):2733-2749. PubMed ID: 38421412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema.
    Altınel MG; Acikalin B; Alis MG; Demir G; Mutibayraktaroglu KM; Totuk OMG; Ardagil A
    Lasers Med Sci; 2021 Sep; 36(7):1545-1553. PubMed ID: 33813612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography angiography assessment of 577 nm laser effect on severe non-proliferative diabetic retinopathy with diabetic macular edema.
    Li ZJ; Xiao JH; Zeng P; Zeng R; Gao X; Zhang YC; Lan YQ
    Int J Ophthalmol; 2020; 13(8):1257-1265. PubMed ID: 32821680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema.
    Bilici S; Serbest E; Ugurbas SH
    Beyoglu Eye J; 2023; 8(3):193-197. PubMed ID: 37766765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity.
    Akkaya S; Açıkalın B; Doğan YE; Çoban F
    Int J Ophthalmol; 2020; 13(10):1606-1611. PubMed ID: 33078112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.
    Elhamid AHA
    Open Ophthalmol J; 2017; 11():164-172. PubMed ID: 28839510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema.
    Bolukbasi S; Cakir A; Erden B; Karaca G
    Cutan Ocul Toxicol; 2019 Dec; 38(4):401-405. PubMed ID: 31438736
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion.
    Garay-Aramburu G; Gómez-Moreno Á; Urcola A
    Eur J Ophthalmol; 2022 May; 32(3):1671-1679. PubMed ID: 34254547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
    Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
    J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
    Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
    Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Subthreshold 532 nm Diode Micropulse Laser with Conventional Laser Photocoagulation in the Treatment of Non-Centre Involved Clinically Significant Diabetic Macular Edema.
    Bougatsou P; Panagiotopoulou EK; Gkika M; Dardabounis D; Konstantinidis A; Sideroudi H; Perente I; Labiris G
    Acta Medica (Hradec Kralove); 2020; 63(1):25-30. PubMed ID: 32422113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study.
    Long H; Liu M; Hu Q; Li X
    BMC Ophthalmol; 2022 Mar; 22(1):105. PubMed ID: 35248003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
    Mishra SK; Sinha S; Chauhan R; Kumar A
    Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy.
    Khodabandeh A; Fadaifard S; Abdollahi A; Karkhaneh R; Roohipoor R; Abdi F; Ghasemi H; Habibollahi S; Mazloumi M
    J Curr Ophthalmol; 2018 Sep; 30(3):245-249. PubMed ID: 30197955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Querques L; Querques G; Lattanzio R; Gigante SR; Del Turco C; Corradetti G; Cascavilla ML; Bandello F
    Ophthalmologica; 2013; 229(1):21-5. PubMed ID: 23006995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.